Journal of acquired immune deficiency syndromes (1999)
High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.
Authors' Reply: Race and the Public Health Impact Potential of Pre-Exposure Prophylaxis in the United States.
Brief Report: Informing Strategies to Build PrEP Capacity Among San Francisco Bay Area Clinicians.
Healthcare Access and PrEP Continuation in San Francisco and Miami After the US PrEP Demo Project.
Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project.
Patterns and Correlates of Participant Retention in a Multi-City Pre-Exposure Prophylaxis Demonstration Project.
The Association of Chronic Pain and Long-Term Opioid Therapy with HIV Treatment Outcomes.
Isoniazid Preventive Therapy for People With HIV Who Are Heavy Alcohol Drinkers in High TB-/HIV-Burden Countries: A Risk-Benefit Analysis.
Abdominal Fat Depots and Subclinical Carotid Artery Atherosclerosis in Women With and Without HIV Infection.
Alcohol and Mortality: Combining Self-Reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected.
